WeVote
Log In

Bill

Bill

HB 6254

AN ACT RELATING TO HUMAN SERVICES -- MEDICAL ASSISTANCE

2025 Regular Session Introduced by Nathan Biah and 9 co-sponsors

Rhode Island Medicaid must cover comprehensive obesity treatment, including FDA‑approved medications and bariatric surgery, starting July 1, 2025, with equal benefit rules.

05/20/2025 Committee recommended measure be held for further study
0
WeVote Research Nonpartisan
Bill Summary · HB 6254

Summary — HB 6254: Medical Assistance (Minimum obesity coverage standards in Medicaid)

Note: The materials provided include text from two different bills numbered HB 6254 (one concerning legislative appropriation procedures in Michigan and one concerning Medicaid coverage in Rhode Island). This summary focuses on the Rhode Island measure titled “AN ACT RELATING TO HUMAN SERVICES — MEDICAL ASSISTANCE,” which matches the given title.

Main purpose

To require the Rhode Island Medicaid program to provide comprehensive coverage for treatment of obesity for Medicaid enrollees, including FDA‑approved anti‑obesity medications, and to authorize the Executive Office of Health and Human Services (EOHHS) to seek any necessary federal waivers or state plan amendments to implement the coverage.

Key provisions

  • Defines “comprehensive coverage for treatment of obesity” to include:
    • Obesity prevention and wellness services
    • Nutrition counseling
    • Intensive behavioral therapy
    • Bariatric surgery
    • FDA‑approved anti‑obesity medications for chronic weight management
  • Effective date for coverage requirement: on and after July 1, 2025.
  • Coverage rules for FDA‑approved anti‑obesity medications:
    • Criteria shall not be more restrictive than the FDA‑approved indications.
  • Parity with other covered conditions:
    • Deductibles, lifetime limits, copayments/coinsurance, and benefit‑year maximums for obesity treatments must be consistent with how other illnesses/conditions are treated under the Medicaid plan.
  • Utilization management:
    • EOHHS may use utilization management to determine medical necessity, provided determinations are made in the same manner as for other covered conditions.
  • Notice requirements:
    • Written notice to Medicaid enrollees about the new coverage—prominently displayed in literature—must be sent within calendar years 2025 and 2026 when annual information is provided and no later than each enrollee’s renewal date.
    • Written notice to healthcare providers and prescribers must be sent in calendar years 2025 and 2026 when annual/provider plan change information is distributed; initial provider notice must be sent no later than October 31, 2025.
  • Federal approvals:
    • EOHHS is directed and authorized to apply for any necessary federal waivers, waiver amendments, and/or state plan amendments (including Section 1115 demonstration waivers) to implement the coverage.

Who is affected

  • Primary: Rhode Island Medicaid enrollees who meet medical necessity criteria for obesity treatment (including those eligible for pharmacotherapy and bariatric surgery).
  • Secondary: Healthcare providers (primary care, bariatric surgeons, behavioral therapists, nutritionists), pharmacies, Medicaid program administrators, and the state budget/healthcare spending.

Procedural status and timeline

  • Introduced in the Rhode Island General Assembly: April 23, 2025; referred to House Finance.
  • Effective upon passage; coverage required on and after July 1, 2025 (subject to federal approvals if required).
  • As provided in the materials, the measure was reported as “committee recommended measure be held for further study” on May 20, 2025 (status may change—check the legislature’s website for updates).

Potential impacts and considerations

  • Access: Expands access to obesity treatments for Medicaid enrollees, including medication and bariatric surgery.
  • Costs: Likely to increase short‑term Medicaid expenditures (pharmacy, procedures, counseling), with potential long‑term cost offsets if obesity‑related comorbidities are reduced; no fiscal estimates are included in the bill text.
  • Implementation: Dependent on timely federal approvals (state plan amendments or 1115 waiver) and on EOHHS operational readiness (provider outreach, formularies, utilization management protocols).

If you want, I can draft a one‑page fiscal impact questions list for the budget office or a plain‑language notice template for enrollees/providers consistent with the bill’s requirements.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.